anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
This study adopts a quasi-experimental design. Eligible subjects are pregnant women 35 to 39 weeks of primipara and their spouses. Specifically, inclusion criteria are (1) gestational age 35 to 39 weeks, (2) adults, (3) primipara and their spouses, (4) having routine prenatal visits and plan to have birth in the medical center, (5) able to communicate with Mandarin or Taiwanese, and (6) willing to participate in this study and give written inform-consent forms. Exclusion criteria are (1) having fetus with abnormality, (2) high-risk pregnancy, and (3) cannot room-in due to newborn's medical conditions. Participants would be assessed on the time points of recruitment (T1), early postpartum during hospitalization (T2), and one-month postpartum (T3).

Before conducting this study, the institutional review board (IRB) has approved this study. The research staffs will approach potential participants during their prenatal visits and invite them to participate in the study. Potential participants would be informed of the study purposes, interventions (routine care for control group, routine care plus intervention for intervention group), and interview contents. After written consent is obtained, the interventions will be arranged. In order to control the quality of data collection, the investigators will train the research assistants. Research training will include ethical concerns about collection of research data, methods of approaching eligible subjects, interviewing techniques, and pilot testing of data collection. The training will provide research assistants by the PI and Co-PI of this study.
The informed consent portion (20) of the system comprises a visual component (12), and auditory component (14), and a textual component (16). The visual component (12) consists of a visual representation of the surgery, preferably in three-dimensional form. The auditory component (14) consists of a narration integral with the visual component (12) that explains the visual representation of the surgery. The textual component (16) consists of a summary of each complication associated with the surgery. The system includes an input device for inputting an acknowledgment of each complication, and a storage device for storing the patient's (22) acknowledgment of each complication. For the purposes of surgical outcome tracking, the input device further allows a user to input outcome information.
The present invention relates to a tumor-targeting protein or a fragment thereof, an antibody binding thereto and a use thereof. More specifically, the present invention relates to a vector containing a nucleic acid coding for the protein A56 or a fragment thereof, and a use thereof. In addition, the present invention relates to an antibody binding to the protein A56 or a fragment thereof, and a use thereof. The vector containing the nucleic acid coding for the protein A56, a fragment thereof or a mutant thereof of the present invention uses an oncolytic virus as the vector, and thus, when administered in an individual, specifically kills only cancer cells, primarily. In addition, cancer cells which have survived even after being infected with the oncolytic virus express the protein A56 on the cell surfaces thereof, and thus may be targeted for secondary anticancer therapy. Thus, cancer may be effectively treated when the vector containing the nucleic acid coding for the protein A56 or a fragment thereof, and the antibody binding to A56, according to one embodiment of the present invention, are used.
The invention discloses traditional Chinese medicine bath foam. The traditional Chinese medicine bath foam is mainly used for smearing bodies during taking a bath and plays roles in cleaning the bodies and removing dust, oil stain and skin secretions. Secondly, the traditional Chinese medicine bath foam has fragrance and alleviates the fatigue state of the human bodies to a certain extent. The pure natural plant bath foam without chemical additives is prepared by using a water vapor distillation method for extracting effective components in pogostemon cablin, schizonepeta, rhizoma nardostachyos, elecampane, clove, acorus tatarinowii, perilla leaf, herba taxilli and ficus microcarpa aerial roots serving as raw materials. The raw materials are selected from Chinese pharmacopoeia, and the used raw materials are decoction pieces. The raw materials have the effects of enlivening the spleen, tonifying qi, nourishing and harmonizing the stomach, promoting the circulation of qi to remove humidity, regulating vital energy and relieving exterior syndromes. The traditional Chinese medicine bath foam prepared from the raw materials also has the effects of promoting the circulation of qi to remove humidity, regulating vital energy and relieving exterior syndromes. Moreover, as the medicines have aromatic volatility, the traditional Chinese medicine bath foam has natural plant aroma different from that of chemical synthetic materials.
The invention discloses a Chinese herbal medicine compound for treating vasculitis, pertaining to the field of Chinese herbal medicine, which is made from following raw materials according to certain weight ratios: 20 to 30 grams of Chinese angelica, 10 to 20 grams of spatholobus stem, 15 to 25 grams of danshen root, 5 to 15 grams of frankincense, 3 to 8 grams of asarum, 15 to 25 grams of szechwan lovage rhizome, 5 to 15 grams of radix cyathulae, 3 to 8 grams of safflower, 10 to 20 grams of rehmanniae praeparatum and 20 to 30 grams of radix astragali. The above raw materials are immersed into water for 2 hours and decocted with water for 30 minutes and then the medicine liquid is poured out; proper water is poured into the pan and decocted for 30 minutes and then the medicine liquid is poured out; the two parts of medicine liquid are mixed together and distilled to remove water with mild fire. The medicine is taken after meals. Each dose of the decoction is taken in a day. Each dose is divided into two parts for twice oral taking in a day. The medicine is taken continuously for 30 days as one course. With extensive sources of raw materials, easy obtaining, low price and no toxic nor side effect, the invention can take effect of blood enriching and mixing, urination promoting and detumescence, pathogenic heat removing from blood and dredging meridian, relieving pain.
BACKGROUND: The use of human cadaveric dissection forms an essential part of teaching anatomy to health sciences students in Malawi. Despite worldwide struggles in acquiring sufficient human cadavers for anatomy education, the current recommendations on the best anatomy practices require the use of cadavers exclusively from the body donation programs. The current study aims to describe the sources of cadaveric bodies used for anatomy education in the Malawian context and reflect on the feasibility of using cadavers from the body donation program only.
METHODS: A retrospective audit of the cadaveric records for the 2006-2022 academic years at the Kamuzu University of Health Sciences was done. The perceived challenges when sourcing the cadavers were identified and described based on the authors experiences in Malawi.
RESULTS: The majority (97.3%) of the cadavers used between 2006 and 2022 were unclaimed bodies. The mean age of the cadavers was 45 years. Most (95.6%) of the unclaimed bodies were males. All the unclaimed bodies were sourced from hospitals. The body donation program in Malawi was patronized by populations of European descent only. Strongly held sociocultural and religious beliefs as well as economic reasons were perceived as significant barriers to acquiring cadavers of the indigenous Malawians through the body donation program.
CONCLUSION: Cadavers for anatomy education in Malawi are mainly from unclaimed bodies, similar to other African countries. The authors support the transition from using "mostly unclaimed bodies (and, less often, body donation)" to using "mostly body donation (and, less often, unclaimed bodies)" through awareness campaigns that are targeted to address the prevailing challenges.
BACKGROUND: Asthma is a prevalent chronic respiratory disease that affects individuals from childhood to adulthood. This study aimed to investigate the association between symptoms and severity of asthma with television viewing, computer and Internet use in adolescents, considering the lifestyle changes in recent decades.
METHODS: This study was conducted in early 2020 as part of the Global Asthma Network 2020 survey, among 13-14-year-olds in Yazd, Iran. Participants were classified into case and control groups based on the presence and severity of asthma symptoms. The data was collected and analyzed using SPSS-20 software to compare the participants based on their screen time.
RESULTS: The analysis of data collected from a total of 5141 students produced noteworthy results. A significant correlation was identified between the occurrence of wheezing in the past year, the presence of severe asthma, and the amount of time spent watching television, using a computer, or internet. The unadjusted model revealed that screen time of more than three hours, pet ownership, current smoking, and ever smoking were all significant predictors of wheezing and severe asthma. Smoking was the strongest predictor of asthma and its severity. After adjusting for confounding factors, the multiple logistic regression model confirmed that screen time of more than three hours remained a significant predictor of both asthma and its severity.
CONCLUSION: This study finds a significant association between media usage and asthma symptoms and severity. However, this association is influenced by lifestyle factors such as physical activity, obesity, diet, and exposure to indoor allergens. Further research is needed to better understand the complex interplay between media usage and asthma, considering the impact of these factors.
Patients receive guadecitabine SC on days 1-5. Treatment repeats every 4-8 weeks for up to 24 courses in the absence of disease progression or unacceptable toxicity. Patients with stable disease after 3 courses are taken off therapy after 6 courses. Patients may continue to receive treatment after 24 courses if the investigator determines it is in the patient's best interest.
A method for monitoring and dispensing controlled substances is provided with a plurality of medical records stored on an external server. Each of the medical records consists of at least one controlled substance data that details the medication required by a patient. When a specific medical record is selected from the plurality of medical records, the specific medical record is matched with a controlled substance stored in a substance storage unit. Based on the at least one controlled substance data, a specified volume of the controlled substance is dispensed. Upon dispensing the specified volume into a syringe or other comparable holding device, the specified volume in the syringe is labelled with patient identification information. As a result, misuse and waste is prevented.
The present invention relates to a system and method for monitoring and predicting the mental health of a person. Data is collected from multiple sensors including a camera and microphone. Additional sensors can be added to improve the robustness of the system such as heart rate sensors and respiration sensors. The data can be collected in phases that provide contextual awareness to the system. An algorithm can synchronize the data collected in the different phases and the data can be analyzed individually and collectively. Historical data can be included in the analysis to evaluate and predict the mental condition of a person.
Adolescent Idiopathic Scoliosis (AIS) is defined as a deformity characterized by abnormal spinal curve formation and rotation of the vertebrae in the coronal plane in a healthy individual aged 10 years and older, without any known cause.This study aimed to investigate the effect of pilates-based exercise training applied with hybrid telerehabilitation method on Cobb angle, respiratory function, respiratory muscle strength and functional capacity in patients with AIS, including postural corrections and breathing pattern determined by curve type-localization. Within the scope of the study, 32 patients diagnosed with AIS, aged 10-18 years, were randomized and divided into education and control groups. Cobb angle measurement, trunk rotation angle measurement, respiratory function test, respiratory muscle strength, functional capacity were evaluated in all patients. Training and control groups participated in supervised sessions once a week during the first 2 weeks of exercise training processes. During these sessions, the patients were informed about the basics of pilates, the postural corrections determined according to the curve type and localization, and the respiratory principles. For the next 10 weeks, the training group took synchronous online sessions with a physiotherapist 3 days a week, and the exercises were continued at home for 4 days. The control group, on the other hand, continued the same exercises 7 days a week, home-based for 10 weeks. At the end of 12 weeks, all assessments were repeated.
Chronic pain (pain that lasts for more than 3 months) can limit physical functioning and negatively affect a person socially and emotionally. Chronic low back pain (that is not caused by cancer) is a very common condition that affects up to a third of people in the US at any time. The primary objective of the trial is to assess functionality changes over a minimum period of 9 weeks using the Oswestry Disability Index (ODI) - a questionnaire to measure disability - in patients with non-malignant chronic low back pain who are taking short-acting opioids chronically, and who initiate treatment with Duragesic® (transdermal fentanyl). The patch delivers fentanyl in doses of 25, 50, 75, or 100 micrograms per hour. The ODI is comprised of 10 sections; each section consists of 6 response alternatives. The 10 scales assessed by the ODI are Pain Intensity, Personal Care (washing, dressing, etc.), Lifting, Walking, Sitting, Standing, Sleeping, Sex Life, Social Life, and Traveling. The secondary objective is to assess changes in health-related quality of life (HRQoL) over the treatment period using the Total Pain Experience (TPE) subscale of the Treatment Outcomes in Pain Survey (TOPS), a questionnaire designed to measure HRQoL changes in patients with chronic pain. The TOPS contains 112 items that are scored into 16 scales. These scales include: Pain Symptoms, Lower Body Functional Limitations, Upper Body Functional Limitations, Perceived Family/Social Disability, Objective Family/Social Disability, Objective Work Disability, TPE (a combination of 5 other scales), Life Control, Passive Coping, Solicitous Responses, Work Limitations, Fear Avoidance, Patient Satisfaction with Outcomes, Health Care Satisfaction, Vitality, and Mental Health (the last two from a questionnaire known as the Short Form-36, or SF-36. Fentanyl transdermal system (skin patch) in a dosage prescribed by the clinical investigator according to the usual standard of care.
PCT No. PCT/JP84/00071 Sec. 371 Date Oct. 17, 1984 Sec. 102(e) Date Oct. 17, 1984 PCT Filed Feb. 28, 1984 PCT Pub. No. WO84/03439 PCT Pub. Date Sep. 13, 1984.Silica base material for dentifrice having excellent transparency, prolonged stability and desired abrasiveness, has specific surface areas measured by BET method and CTAB method of 5-60 m2/g respectively with a difference therebetween of less than 40 m2/g, and having a refractive index of 142-1.45. This base material can be prepared by reacting an alkali metal silicate solution with hydrochloric acid or sulfuric acid in the presence of an electrolyte in two stages, a silica crystallization stage in which the pH of the reaction system is brought to 10.0, and a neutralization stage in which the pH of the reaction system is brought to 8.0-6.5, completing the neutralization stage within 30 minutes and aging the neutralized mixture for at least 10 minutes. The ratio of the rate of addition of chloride or sulfate ions between the neutralization and crystallization stages is at least 5:3.
BACKGROUND: Accelerated neuropathy is a rare syndrome of rapidly worsening peripheral neuropathy, typically described in end-stage kidney disease (ESKD) patients undergoing dialysis. In our center, we encountered a surge in the occurrence of accelerated neuropathy among ESKD patients undergoing hemodialysis, which prompted systematic research.
METHODS: In this case-control study, we present the clinical features, electrophysiologic findings, and outcome of a series of patients who developed accelerated neuropathy after commencing hemodialysis for ESKD. Those who initiated hemodialysis and did not develop accelerated neuropathy were included as controls. We used logistic regression to identify predictors of accelerated neuropathy.
RESULTS: Among 436 ESKD patients who initiated hemodialysis over 4 years, 17 were diagnosed with accelerated neuropathy. The median-time (interquartile range) from hemodialysis initiation to presentation with accelerated neuropathy was 3 weeks (2-6). It typically presented as acute onset of unsteadiness of gait necessitating assistance for ambulation. Electrophysiology revealed length-dependent symmetric sensorimotor axonal neuropathy. Diabetes mellitus (odds ratio [OR] 4.1, 95% CI 1.2-13.9, p = 0.02), pre-existing peripheral neuropathy (OR 9.25, 95% CI 2.79-30.6, p < 0.001), and serum alkaline phosphatase (OR 1.2 for every 10 U increase, 95% CI 1.00-1.52, p = 0.04) significantly predicted accelerated neuropathy. With continued dialysis and supportive care, neurologic status improved, total-neuropathy score (summary score of peripheral nerve dysfunction incorporating clinical and electrophysiological parameters) declined from 26.5 to 18.4 (p < 0.001) and most regained unassisted ambulation.
CONCLUSION: This study presents the largest series of patients with accelerated neuropathy and has identified predictors. However, in view of the unusually high incidence of accelerated neuropathy we speculate that other unidentified factor(s) could be underlying its pathogenesis.
The patient will lay prone on the adjustment table 5 minutes, the approximate equivalency of a Logan Basic adjustment. Table will be in proper position according to Logan Basic protocol.
CA-M consisted of in-person training for veteran/care-ally dyads to learn a standardized 30-minue massage routine, instructional DVD, and printed treatment manual. Participants were to complete three care ally-assisted massage sessions weekly for 12-weeks.
According to the World Health Organization, compared to two hundred health conditions, depression is ranked as the second leading cause of disability worldwide. The annual prevalence of Major Depressive Disorder (MDD) in the United States is estimated at 7% and the lifetime risk approximately 17%. Depression is associated with approximately 75% of all deaths by suicide, resulting in immense suffering for families and society at large. 83 billion dollars are spent per year on treatment and lost productivity related to the disorder. Current treatments for MDD have remission rates between 35-50%. Patients who respond to treatment, but do not experience clinical remission are at markedly increased risk for relapse. Approximately 50% of patients treated with two trials of antidepressant interventions do not achieve clinical remission. Consequently, novel evidence-based treatment modalities that can further treat this devastating disorder are needed. Mind-body interventions constitute a large and diverse group of practices that reduce both stress and inflammation and are increasingly being evaluated in the treatment of MDD The 2007 NHIS concluded that 16.6% of U.S. adults, representing 34.1 million Americans, used at least one mind-body intervention in the past year. Initial studies with different mind-body interventions have been shown to improve outcomes in MDD. A recent meta-analysis gave a Grade B for current evidence for the use of yoga as an intervention for MDD. Sudarshan Kriya Yoga (SKY) is a advanced yogic breathing intervention that has been reported to relieve symptoms of major depressive disorder and generalized anxiety disorder. In MDD, SKY can correct the P300 amplitude, decrease plasma cortisol levels and increase plasma prolactin levels. In a small-scale randomized controlled trial, 45 consenting inpatients meeting criteria for DSM-IV severe, melancholic depression were randomized to receive SKY, electroconvulsive therapy (ECT) or imipramine treatment for four weeks (Janakiramaiah et al. 2000). Consequently, the rigorous evaluation of a multicomponent yogic intervention featuring SKY as an adjunctive treatment for adults with MDD warrants further study.
FIELD: medicine. SUBSTANCE: the suggested tablets are presented in two variants. According to the first variant, tablet's core contains pyracetam and additional substances - potato starch, polyvinylpyrrolidone, either lactose or magnesium carbonate or calcium stearate. Tablets are covered with membrane containing gelatin, gum arabic, glucose, magnesium carbonate, titanium dioxide, talc, hydroxypropylmethylcellulose, tropeolin 0 and sugar. According to the second variant, tablets, at the same quantitative and qualitative composition of their cores, can be covered with membrane including polyvinylpyrrolidone, magnesium carbonate, aerosil, titanium dioxide, tropeolin 0, bee wax, sunflower oil and sugar. EFFECT: improved stability at storage. 2 cl
Carboplatin injection should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents. Appropriate management of therapy and complications is possible only when adequate treatment facilities are readily available.

Bone marrow suppression is dose related and may be severe, resulting in infection and/or bleeding. Anemia may be cumulative and may require transfusion support. Vomiting is another frequent drug related side effect.

Anaphylactic-like reactions to carboplatin have been reported and may occur within minutes of carboplatin injection administration. Epinephrine, corticosteroids, and antihistamines have been employed to alleviate symptoms.
PURPOSE OF REVIEW: Despite decades of development and testing of weight-loss interventions, the adult populations worldwide have witnessed a continuous rise in body weight. There is an ongoing debate about how to move forward. Some argue that this rise calls for more intensive and possibly life-long treatments, including the new effective GLP1 weight loss medications, while others have called for a fundamental shift away from weight and on to a broader understanding of health. The two strategies are represented as a weight-centric health strategy and a weight neutral health strategy. This paper debates the benefits and potential harms related to the use of these two strategies.
RECENT FINDINGS: While major weight loss may have substantial health benefits, many individuals will need intensive treatment including weight loss medication to achieve it, as generally few are able to sustain a lifestyle induced weight loss in the long term. Both the weight loss and the weight-neutral health strategies have advantages and limitations emphasizing the need for further research comparing the two strategies. Currently, not everyone is offered, can afford, will tolerate or even desire treatment with weight loss medication, and weight neutral health strategies may be a desirable alternative intervention offering a more holistic approach to health and addressing psychological and social issues including the burden of experienced and internalized weight stigma. However, this method still needs to be tested for effectiveness with regards to both physical and long-term psychological benefits.